{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:41:27Z","timestamp":1760013687607,"version":"3.37.3"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["H2020-SC1-BHC-2018-2020"],"award-info":[{"award-number":["H2020-SC1-BHC-2018-2020"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010805","name":"Fundaci\u00f3n Tatiana P\u00e9rez de Guzm\u00e1n el Bueno","doi-asserted-by":"publisher","award":["IIBSP-DOW- 2020-151"],"award-info":[{"award-number":["IIBSP-DOW- 2020-151"]}],"id":[{"id":"10.13039\/501100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R61AG066543-01","1R01AG056850-01A1","R21AG056974","R01AG061566,1R01AG081394-01"],"award-info":[{"award-number":["1R61AG066543-01","1R01AG056850-01A1","R21AG056974","R01AG061566,1R01AG081394-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT006\/17\/00119"],"award-info":[{"award-number":["SLT006\/17\/00119"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011995","name":"Fundaci\u00f3 Privada d'Investigaci\u00f3 Sant Pau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/01473","PI23\/01786","INT21\/00073"],"award-info":[{"award-number":["PI20\/01473","PI23\/01786","INT21\/00073"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ebiom.2024.105387","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T22:32:46Z","timestamp":1727994766000},"page":"105387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Context matters: the evolving use of biomarkers in Alzheimer's disease care"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1340-638X","authenticated-orcid":false,"given":"Juan","family":"Fortea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2024.105387_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.0000000000207193","article-title":"Blood biomarkers in neurodegenerative diseases: implications for the clinical neurologist","volume":"101","author":"Alcolea","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105387_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105387_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ebmed-2017-110862","article-title":"Interactive visualisation for interpreting diagnostic test accuracy study results","volume":"23","author":"Fanshawe","year":"2018","journal-title":"BMJ Evid Based Med"},{"year":"2024","series-title":"Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease","author":"Sch\u00f6ll","key":"10.1016\/j.ebiom.2024.105387_bib4"},{"year":"2024","series-title":"Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer\u2019s disease and Down syndrome","author":"Carmona-Iragui","key":"10.1016\/j.ebiom.2024.105387_bib5"},{"key":"10.1016\/j.ebiom.2024.105387_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104547","article-title":"Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study","volume":"90","author":"Montoliu-Gaya","year":"2023","journal-title":"eBioMedicine"},{"year":"2024","series-title":"The use of biomarkers in the diagnosis of Alzheimer\u2019s disease in adults with intellectual disability","author":"McFeely","key":"10.1016\/j.ebiom.2024.105387_bib7"},{"year":"2024","series-title":"Biomarkers of neurodegeneration across the Global South","author":"McGlinchey","key":"10.1016\/j.ebiom.2024.105387_bib8"},{"year":"2024","series-title":"Insights into the use of biomarkers in clinical trials in Alzheimer\u2019s disease","author":"Pascoal","key":"10.1016\/j.ebiom.2024.105387_bib9"},{"year":"2024","series-title":"Alzheimer\u2019s disease biomarkers and the tyranny of treatment","author":"Karlawish","key":"10.1016\/j.ebiom.2024.105387_bib10"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T21:22:45Z","timestamp":1729545765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":10,"alternative-id":["S2352396424004237"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105387","relation":{},"ISSN":["2352-3964"],"issn-type":[{"type":"print","value":"2352-3964"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Context matters: the evolving use of biomarkers in Alzheimer's disease care","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105387"}}